Vincera Pharma Inc
(VINC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 85,623 | 53,355 | 61,792 | 0 | 0 |
| Other current assets | 0 | 0 | 214 | 0 | 0 |
| TOTAL | $86,505 | $54,408 | $63,110 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 228 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 4,404 | 3,592 | 82 | 0 | 0 |
| TOTAL | $4,632 | $3,592 | $82 | $N/A | $N/A |
| Total Assets | $91,137 | $58,000 | $63,192 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,830 | 461 | 5,505 | 0 | 0 |
| Accrued Expenses | 2,397 | 1,390 | N/A | 0 | 0 |
| Other current liabilities | 11,097 | 27,224 | 32,308 | 0 | 0 |
| TOTAL | $15,684 | $29,171 | $37,813 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,858 | 3,276 | 0 | 0 | 0 |
| TOTAL | $3,858 | $3,276 | $N/A | $N/A | $N/A |
| Total Liabilities | $19,542 | $32,447 | $37,813 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 876 | 876 | 699 | 1,042 | N/A |
| Common Shares | 1 | 1 | 1 | 0 | 0 |
| Retained earnings | -24,975 | -22,941 | -16,665 | 0 | 0 |
| Other shareholders' equity | 0 | -8,182 | 0 | 0 | 0 |
| TOTAL | $71,595 | $25,553 | $25,379 | $0 | $0 |
| Total Liabilities And Equity | $91,137 | $58,000 | $63,192 | $0 | $0 |